Catalyst Pharmaceutical Partners Inc buy BiotechBee
Start price
08.09.24
/
70%
€17.48
Target price
30.04.27
€21.00
Performance (%)
18.14%
End price
14.12.24
€20.65
Summary
This prediction ended on 14.12.24 with a price of €20.65. The BUY prediction by BiotechBee finished with a performance of 18.14%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.391% | 3.391% | 0.932% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Catalyst Pharmaceutical Partners Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
In the thread Trading Catalyst Pharmaceutical Partners Inc
Stopped prediction by BiotechBee for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.76
23.02.25
23.02.25
€35.00
31.01.27
31.01.27
11.46%
30.03.25
30.03.25
Could be very worthwhile Investment >20% year
